-transparent.png){kind=logo}
OBJECTIVE Fracture liaison services (FLS) use a multidisciplinary approach to treat patients who have experienced an osteoporotic fracture to reduce the risk of subsequent fractures. To date, there has been minimal FLS implementation in Latin America where fractures continue to be undertreated. This study aims to estimate the number of fractures averted, bed days avoided, and costs saved resulting from universal FLS implementation in Brazil, Mexico, Colombia, and Argentina. METHODS A calculator was developed to estimate the annual benefits of FLS programs in Brazil, Mexico, Colombia, and Argentina from a public hospital perspective. It was assumed all patients with a hip, vertebral, or wrist fracture were referred to an FLS program. Country-specific data were obtained from a previous systematic review and interviews with osteoporosis experts. Hospitalization and post-hospitalization costs were expressed in 2019 USD without discounting. Costs of FLS implementation were not considered. RESULTS In 2019, the number of FLS patients prevented from having a subsequent hip, vertebral, or wrist fracture was estimated as 15,607 in Brazil, 8,168 in Mexico, 5,190 in Argentina, and 2,435 in Colombia with total bed days saved of 142,378 in Brazil, 75,877 in Mexico, 52,301 in Argentina, and 21,725 in Colombia. The annual cost savings in 2019 were highest in Argentina (28.1 million USD), followed by Mexico (19.6 million USD), Brazil (7.64 million USD) and Colombia (3.04 million USD). Over five years (2019-2023) the cumulative cost savings were 145 million USD in Argentina, 106 million USD in Mexico, 40.5 million USD in Brazil, and 16.1 million USD in Colombia. CONCLUSIONS Universal FLS implementation in Brazil, Mexico, Colombia, and Argentina was predicted to prevent 31,400 fractures, avoid 292,281 bed days, and save 58.4 million USD in 2019, though caution is warranted in the interpretation of these results due to high uncertainty. Increased implementation of FLS programs in Latin American countries may help to realize these benefits.
Rima Aziziyeh, and
Javier Garcia Perlaza, and
Najma Saleem, and
Hannah Guiang, and
Kirk Szafranski, and
Rebecca K McTavish
April 2022,
Archives of osteoporosis,
Rima Aziziyeh, and
Javier Garcia Perlaza, and
Najma Saleem, and
Hannah Guiang, and
Kirk Szafranski, and
Rebecca K McTavish
July 2010,
Journal of Ayurveda and integrative medicine,
Rima Aziziyeh, and
Javier Garcia Perlaza, and
Najma Saleem, and
Hannah Guiang, and
Kirk Szafranski, and
Rebecca K McTavish
January 1974,
International journal of clinical pharmacology, therapy and toxicology,
Rima Aziziyeh, and
Javier Garcia Perlaza, and
Najma Saleem, and
Hannah Guiang, and
Kirk Szafranski, and
Rebecca K McTavish
April 2013,
Multiple sclerosis and related disorders,
Rima Aziziyeh, and
Javier Garcia Perlaza, and
Najma Saleem, and
Hannah Guiang, and
Kirk Szafranski, and
Rebecca K McTavish
December 2021,
Value in health regional issues,
Rima Aziziyeh, and
Javier Garcia Perlaza, and
Najma Saleem, and
Hannah Guiang, and
Kirk Szafranski, and
Rebecca K McTavish
January 2003,
Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
Rima Aziziyeh, and
Javier Garcia Perlaza, and
Najma Saleem, and
Hannah Guiang, and
Kirk Szafranski, and
Rebecca K McTavish
October 2023,
Archives of osteoporosis,
Rima Aziziyeh, and
Javier Garcia Perlaza, and
Najma Saleem, and
Hannah Guiang, and
Kirk Szafranski, and
Rebecca K McTavish
April 1982,
Journal of biosocial science,
Rima Aziziyeh, and
Javier Garcia Perlaza, and
Najma Saleem, and
Hannah Guiang, and
Kirk Szafranski, and
Rebecca K McTavish
January 2014,
Annals of global health,
Rima Aziziyeh, and
Javier Garcia Perlaza, and
Najma Saleem, and
Hannah Guiang, and
Kirk Szafranski, and
Rebecca K McTavish
January 1999,
Neuroepidemiology,
